Cellectar Biosciences Inc (NASDAQ:CLRB) traded at $0.33 at last check on current trade day and made an upward move of 3.18% on its previous day’s price.
On the other hand, looking at the outlook for the CLRB stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of 50% Sell.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Cellectar Biosciences Inc (CLRB) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 9.28% off its SMA20 and 14.39% from its 50-day simple moving average. The RSI (14) is pointing at 55.21 while the volatility over the past week is 8.07% and jumps to 8.67% over the past one month. The beta value is 0.70, while the average true range (ATR) is currently pointing at 0.03. The average price target for the stock over the next 12 months is $12, with the estimates having a low of $12 and a high of $12. These price ends are -3536.36% and -3536.36% off the today’s price level respectively, although investors could be excited at the prospect of a -3536.36% if the CLRB share price touches on the median price of $12.
